Here are the 10-K annual reports from 3M Company (MMM) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow MMM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MMM filings page.
3M Company filed its 10-K reporting 2025 net sales of $24,948 million, up 1.5%, with organic sales up 0.9%. GAAP operating margin was 18.6% and adjusted margin 23.4%, reflecting productivity gains but also higher PFAS-related litigation and transformation costs.
GAAP EPS was $6.00, down 17%, while adjusted EPS rose 10% to $8.06, helped by lower restructuring, growth investments and a gain on an investment. 3M completed its exit from PFAS manufacturing by year-end 2025, continues to manage substantial PFAS liabilities including the PWS Settlement of $10.5–$12.5 billion through 2036, and will contribute $6.0 billion under the Combat Arms Earplug settlement through 2029.
The company spun off its Health Care business as Solventum in 2024, now reported as discontinued operations, and is managing related dis-synergies and transition agreements. 3M maintained a global footprint with about 60,500 employees and repurchased 3.4 million shares in Q4 2025 under a $7.5 billion buyback authorization.